Navigation Links
Uses of medications in psychoanalysis
Date:1/9/2008

As Americans increasingly seek a quick fix to physical and mental ailments, psychoanalysts can be caught in the crossfire of a debate about the potential benefits and drawbacks of including medication in their treatment plans. A panel discussion entitled, The Uses of Medications in Psychoanalysis: What We Know; What is Uncertain, will be led by internationally renowned psychoanalyst Glen O. Gabbard, M.D., at the American Psychoanalytic Associations 2008 Winter Meeting. The panel discussion will be held on Friday, January 18, 2008, from 2-5 p.m. at the Waldorf Astoria Hotel in New York. Media are invited to attend.

Taking the position for a cautious approach to the inclusion of medications in analysis will be Stephen D. Purcell, M.D., whose paper titled The Analysts Attitude toward Pharmacotherapy will be published in the Journal of the American Psychoanalytic Association (JAPA) in 2008. Adele Tutter, M.D., Ph.D., is more optimistic about the inclusion of medications in treatment and her article, Medication as Object, was published in JAPA. The panel discussion will be chaired by Richard M. Gottlieb, M.D., and the discussant will be Dr. Gabbard.

Instead of perceiving the use of medications in competition with analysis, we should educate our patients about the potential costs and benefits of including medication in an analytic treatment. Then, patients can make informed decisions about their treatment options, says Dr. Tutter. While we analysts value insight and introspection, some patients dont value these things and should be allowed to choose.

Im not taking the position that combined treatments that include medication and analysis should not be done. Instead, I believe they must be considered very carefully, says Dr. Purcell. An analyst's decision to combine medication with a psychoanalysis is also a tacit communication that under some circumstances can be an interference to psychoanalytic processes of change. The panel discussion is open to members of the media, mental health practitioners, students, and the public.


'/>"/>

Contact: Dottie Jeffries
djeffries@apsa.org
212-752-0450 x29
American Psychoanalytic Association
Source:Eurekalert

Related medicine news :

1. AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks with ADHD Medications
2. Diet and medications may assist prevention of prostate cancer
3. Cautious Optimism for New Alzheimers Medications, Reports the Harvard Mental Health Letter
4. Patients cant recall their medications to tell doctors
5. The American Pharmacists Association Supports Consumer Education About OTC Medications
6. Combining Medications Often Best Strategy to Battle Rheumatoid Arthritis
7. Many Osteoporosis Medications Prevent Fractures, But None Is Proven Best
8. Cost of glaucoma medications may impact treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... Yorba Linda, Ca (PRWEB) , ... March 29, ... ... a standard process in many scientific laboratories. The assembly protocols involve many repetitive ... is well suited for automation, which enables the high-throughput needed, and results in ...
(Date:3/29/2017)... ... March 29, 2017 , ... The Wharton School of the University of Pennsylvania ... have made a $10 million gift to establish the Ken Moelis and Julie ... pathway to a Wharton MBA for highly-qualified Penn undergraduates whose academic and career interests ...
(Date:3/28/2017)... ... March 28, 2017 , ... For many women, getting birth control isn’t as easy as ... they either don’t have access to a health care facility or a pharmacy within 60 ... of the United States or for many who are faced with health or personal issues ...
(Date:3/28/2017)... ... ... The Thyroid Secret is a specialized 9-part documentary series ... recently launched on March 1, and Dr. Wentz discussed varied benefits and aspects ... Wentz is a licensed pharmacist and a foremost thyroid specialist. After being diagnosed ...
(Date:3/28/2017)... ... March 28, 2017 , ... Via Oncology, the leading provider ... a free, public-facing tool for analyzing the costs of various drug regimens in ... information to patients, providers, insurers and pharmaceutical companies about the estimated costs of ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , USA, March 29, 2017 Stryker announced ... Cares by People magazine, in partnership with Great Place ... companies on the list. This list highlights the top ... succeeded in business while also demonstrating respect, compassion and ... To determine the companies on the ...
(Date:3/29/2017)... 29, 2017 On March 28, the U.S. Food and ... with relapsing forms of multiple sclerosis (MS) and primary ... approved by the FDA for PPMS. Ocrevus is an ... "Multiple sclerosis can have a profound impact ... M.D., director of the Division of Neurology Products in ...
(Date:3/29/2017)... March 29, 2017 FinancialBuzz.com News Commentary  ... Data published in a research report by ... reach a value of USD 55.8 billion by 2025. The projection takes ... States and a more open approach towards cannabis products around ... Florida , North Dakota , ...
Breaking Medicine Technology: